Browse Category

Investment Analysis News 11 October 2025 - 14 October 2025

Nouveau Monde Graphite Stock Skyrockets – Future EV Battery King or Overvalued Hype?

Nouveau Monde Graphite Stock Skyrockets – Future EV Battery King or Overvalued Hype?

Stock Performance and Market Reaction NMG’s share price has been exceptionally volatile. After closing US$3.34 on Oct 10, 2025, the stock jumped to around $5.45 by the Oct 13 after-market benzinga.com. Trading volume on Oct 13 spiked, with MarketBeat reporting a nearly 300% surge from average daily volumes marketbeat.com. This “charge” coincided with broad gains in battery-materials and EV-related equities (e.g. American Battery Tech Co, Almonty Ind. also surged that day benzinga.com). Major headline-driven news directly on Oct 13 was limited, suggesting the move was fueled by momentum and speculation. In recent weeks, analyst commentaries have noted this dichotomy: despite
Tata Stock Split Frenzy: Tata Investment Shares Soar 25% in Two Days, Record Date Set – What Investors Should Know

Tata Motors Stock Crash 40%: $4B EV Gamble, JLR Turmoil & Analyst Verdicts

Metric Q1 FY2026 (Apr–Jun ’25) Q1 FY2025 (Apr–Jun ’24) YoY Change Revenue (₹ Cr) 1,03,792 business-standard.com ≈1,06,416 (estimate) –2.5% business-standard.com Net Profit (₹ Cr) 4,003 business-standard.com 10,587 –62.2% business-standard.com Basic EPS (₹) 10.66 (reported) business-standard.com 26.23 (estimate) –59.4% Source: Tata Motors Q1 FY2026 results (Business Standard) business-standard.com business-standard.com. Latest News & Developments Financial Performance Tata Motors’ latest financials show mixed trends: Expert Commentary “For Tata Motors, this split holds the potential for better performance by making the company more focused and stronger,” noted one brokerage, but it quickly added that JLR’s troubles – from the recent cyberattack to slowing demand
NuScale Power (SMR) Stock Rockets 14% on Historic 6GW Nuclear SMR Deal — Analysts Weigh In

NuScale Power (SMR) Stock Rockets 14% on Historic 6GW Nuclear SMR Deal — Analysts Weigh In

Recent News and Stock Momentum In the week of October 13, 2025 NuScale Power made headlines. On Oct 9, Fluor Corporation (NuScale’s original parent) announced it sold 15 million SMR Class A shares for ~$605 million newsroom.fluor.com. Fluor said it will use proceeds to fund stock buybacks and still holds Class B shares representing ~39% equity newsroom.fluor.com. This partial divestment drew investor attention and scrutiny. On Oct 12, Simply Wall St reported on these events and NuScale’s record TVA/ENTRA1 6 GW SMR agreement simplywall.st. The next day (Oct 13) NuScale’s stock soared ~14%, trading as high as $46.40 marketbeat.com before settling near $44.84 by
Quantum Stocks (IonQ, Rigetti, D-Wave, Quantum Computing Inc) Surge 700–6,000% – Bubble or Breakthrough? (Oct. 13, 2025)

Quantum Stocks (IonQ, Rigetti, D-Wave, Quantum Computing Inc) Surge 700–6,000% – Bubble or Breakthrough? (Oct. 13, 2025)

In short: The quantum wave shows no signs of cresting – stocks like IonQ, Rigetti and QUBT continue to race higher on every piece of news. Current share prices, however, embed aggressive future growth that isn’t yet realized. As one commentator put it, many investors are “buying a vision of the future” ts2.tech. The coming months will test whether these parabolic runs are the start of a historic tech breakout or the peak of a frothy bubble. (All data as of mid-October 2025.) Sources: Recent Barron’s/TipRanks reports tipranks.com ts2.tech, TipRanks analyses tipranks.com tipranks.com, and TechStock² (TS2.tech) deep-dives on IonQ, Rigetti,
Tech ETFs Explode (and Implode) After Trade Truce: QQQ Rockets as TQQQ Traders Cash Out – What’s Next?

Tech ETFs Explode (and Implode) After Trade Truce: QQQ Rockets as TQQQ Traders Cash Out – What’s Next?

Market Recap: Trade Truce Sends QQQ Higher QQQ, the Nasdaq-100 ETF, tracks the 100 largest non-financial companies on Nasdaq (heavy in Apple, Microsoft, Amazon, etc.) azat.tv. On Friday Oct 10, QQQ plunged ~3.5% as President Trump announced plans to double tariffs on Chinese imports and restrict rare-earth exports, renewing trade war fears tipranks.com reuters.com. This knocked major tech shares lower (for example, Friday’s Nasdaq Composite lost ~820 points) and dragged QQQ to a 5-day decline of about 2.9% tipranks.com. Over the weekend Trump backpedaled, tweeting that he didn’t want to “hurt” China and that things would be fine, which soothed
Oklo (OKLO) Stock Goes Nuclear: DOE Contracts Trigger Explosive Rally – Analysts Weigh In

Oklo (OKLO) Stock Goes Nuclear: DOE Contracts Trigger Explosive Rally – Analysts Weigh In

Current Stock Performance Oklo’s stock has been extremely volatile in October 2025. On Oct 10 it traded in a $136.80–$161.35 range and closed at $147.16 stockinvest.us (a 6.5% gain for the day). Volume has surged (38.8M shares on Oct 10 vs ~16.6M on Oct 9) stockinvest.us. Year-to-date, the stock is up roughly 500% (even over 1,100% since late 2024) ts2.tech, reflecting explosive investor interest. For context, StockInvest.us notes the 52-week trading range is about $9–$161 stockinvest.us, illustrating how Oklo went from penny-stock levels post-SPAC to a ~$20B market cap in 2025 ts2.tech. Major Company Developments DOE Programs & Projects: In
Palantir (PLTR) Stock Soars on AI Hype – Is It a Bubble or the Next Tech Giant?

Palantir (PLTR) Stock Soars on AI Hype – Is It a Bubble or the Next Tech Giant?

Stock Price & Trend As of Oct 13, 2025, Palantir shares trade around $175 investing.com. The stock has rallied dramatically in recent years – roughly +300% in 2025, +360% over 12 months ts2.tech, making PLTR one of the hottest large-cap tech stocks. On Aug 12, 2025 PLTR hit an all-time high of $190.00 tradingview.com investing.com. Since then it has retreated to the mid-$170s. Trading volume has been unusually high, reflecting intense investor interest (StockTwits noted PLTR as its top-trending ticker in late August even amid a selloff) ts2.tech ts2.tech. Recent Trend: Over the past 2–3 weeks (early Oct 2025), PLTR
ZenaTech (ZENA) Stock: Will It Explode 70% on New Drone & Quantum Breakthroughs? (Oct 2025 Deep Dive)

ZenaTech (ZENA) Stock: Will It Explode 70% on New Drone & Quantum Breakthroughs? (Oct 2025 Deep Dive)

Recent News & Corporate Developments ZenaTech’s stock move this month reflects a flurry of positive news. On Oct. 9, 2025, ZenaTech announced it closed the acquisition of Putt Land Surveying, Inc. (Tucson, AZ), its eleventh land-survey firm acquisition zenatech.com. CEO Shaun Passley remarked that “this acquisition serves as a strategic catalyst” for strengthening its Phoenix-area growth zenatech.com. This deal immediately expands ZenaTech’s Drone-as-a-Service (DaaS) network in central/southern Arizona and brings on skilled survey staff. (Each acquisition is then converted into a local drone-services center, as Passley explains: “after each land survey acquisition ZenaTech moves forward with converting the service to
12 October 2025
Palo Alto Networks (PANW) Stock Skyrockets on AI-Powered Cybersecurity Boom – Can It Keep Going?

Palo Alto Networks (PANW) Stock Skyrockets on AI-Powered Cybersecurity Boom – Can It Keep Going?

Latest Stock Performance PANW stock has rallied in recent months. It closed ~$208.55 on Oct 10, 2025 marketbeat.com and traded near $215–216 on Oct 8–9 ts2.tech. This puts the shares near multi‑month highs, up ~3–4% over the prior week ts2.tech. Year‑to‑date, PANW is up roughly 10–15%, despite some volatility on acquisition news. The stock is still below its all‑time high (~$216 reached in early Oct). Momentum indicators (not shown) suggest bullish technicals, and it trades above key moving averages. Over five years the stock has returned ~37% annually ts2.tech, reflecting strong growth. By comparison, fellow cybersecurity names like CrowdStrike (CRWD)
Data Center Boom Ignites PPL Corp (PPL) Stock Surge – Analysts Weigh In

Data Center Boom Ignites PPL Corp (PPL) Stock Surge – Analysts Weigh In

Recent News and Developments Stock Performance & Valuation PPL shares have risen steadily in 2025. After trading near $31 in early 2024, PPL climbed above $37 by Oct 2025 marketbeat.com. Key metrics (Oct 2025) include a P/E of ~27–28, a PEG ratio ~2.6, and a beta ~0.66 marketbeat.com. Its 50-day moving average (~$36.38) sits just below price, and the 200-day (~$35.39) confirms an uptrend marketbeat.com. The 52-week range is $31.22–$37.81 marketbeat.com. The stock’s valuation looks moderate among utilities. Analysts’ consensus price target (~$37.40 marketbeat.com to $38.8 nasdaq.com) implies only low single-digit upside, reflecting cautious optimism. TS2.tech notes PPL’s financial profile
Quantum Rivals Clash: D-Wave vs Rigetti – Which Stock Will Skyrocket in 2026?

Quantum Rivals Clash: D-Wave vs Rigetti – Which Stock Will Skyrocket in 2026?

Quantum computing remains an emerging field, and D-Wave and Rigetti represent two very different approaches. D-Wave (NYSE: QBTS) is a veteran in quantum annealing – a specialized model for optimization problems. In mid-2025 the company rolled out its 6th‑generation Advantage2 annealer dwavequantum.com dwavequantum.com. Its latest results show solid progress: Q2 2025 revenue of $3.1M (up 42% YOY) and broad customer engagements, but still huge losses. CEO Alan Baratz emphasized the quarter’s achievements: “we brought to market our sixth‑generation quantum computer… ended the quarter with a record $819 million in cash,” and said D-Wave is “confident in our ability to continue delivering long‑term value” dwavequantum.com. Much of the
Merck (MRK) Stock Could Skyrocket: Key Drug Approvals & Analyst Targets Unveiled

Merck (MRK) Stock Could Skyrocket: Key Drug Approvals & Analyst Targets Unveiled

Metric Merck (MRK) Last Price (10/10/25) $86.02 marketbeat.com Market Cap $215B marketbeat.com P/E (TTM) ~13× marketbeat.com Yield 3.8% marketbeat.com 52-Week Range $73.31 – $111.58 marketbeat.com YTD Total Return -11.07% financecharts.com Q2 2025 Sales $15.8B investing.com 2024 Sales $64.2B merck.com 2024 R&D Spend $17.9B merck.com Analyst PT (avg) $104 (12-mo) marketbeat.com Consensus Rating Hold marketbeat.com Company Overview Merck & Co. (MRK, called MSD outside North America) is a global healthcare company (75,000 employees merck.com) organized in Pharmaceuticals, Vaccines and Animal Health. It focuses on oncology/immunology, infectious disease (including vaccines), cardio-metabolic, and hospital specialty medicines merck.com. Its blockbuster product KEYTRUDA® (pembrolizumab) – a PD-1 checkpoint
1 25 26 27 28 29 31
Go toTop